新型N-苯基哌嗪喹啉類衍生物的設計與合成
[Abstract]:Heterocyclic compounds are a very important class of compounds, which play a very important role in the synthesis of organic drugs, mainly depending on their dicyclic and tricyclic derivatives have applied physiological activities in medicine and pesticides. Cyclic compounds, which contain both N and S elements. 1,5-benzothiaza and their derivatives are widely used because they have broad biological activities, such as anti-hypertension, anticonvulsant, anticancer, anti-HIV, anti-ulcer, antibacterial and so on. In addition, they can also be used as calcium ion antagonists and are many analgesics. For example, Diltiazem hydrochloride, a widely used clinical drug, contains heterocyclic structure. At present, the synthesis and research of 1,5-benzothiazole and its derivatives have become an important research hotspot of many pharmaceutical chemists.
Quinoline compounds are important pharmaceutical intermediates in the pharmaceutical industry. In recent years, many new drugs containing quinoline rings have been developed. Quinoline was originally obtained by distillation from quinine, an antimalarial drug. Quinoline is mainly used in the synthesis of antimalarial drugs, such as chloroquine phosphate, primary aminoquine phosphate and aminophenol quinoline. It can also be used to synthesize important local anesthetics, such as dibucaine hydrochloride, antipyretic and analgesic drugs, such as cinchofen and clotridine, as well as quinolidoform, chloroiodoquinoline, bisiodoquinoline, etc. Quinoline rings and other heterocyclic compounds can also be used to synthesize chlorphenamine and clotridine. Previous studies have shown that tetrad and quintuple heterocycles can be successfully constructed by 1,3-dipolar cycloaddition reaction. Considering the splicing principle of drug design, we introduced 1,5-benzothiazide into quinoline nucleus in order to obtain compounds with potential biological activity and provide a basis for the screening of organic drugs. Synthesis methods and lead compounds.
Our main work is to introduce N-phenylpiperazine as a substituent into quinoline heterocyclic molecules and synthesize a series of novel derivatives with potential biological activities by 1,3-dipolar cycloaddition reaction. A series of quinoline derivatives containing N-phenylpiperazine were successfully synthesized.
This thesis is divided into two parts:
The first part is the literature review.
In this part, the important synthetic methods, physiological and pharmacological activities of quinoline, 1,5-benzothiazole and 1,2,4-VA diazole are systematically reviewed, and the 1,5-benzothiazole derivatives and quinoline-containing 1,2,4-VA diazoline derivatives are also briefly introduced. Structural modification of cyclization.
The second part is the experimental part. The main tasks are as follows:
1, the synthesis and characterization of novel quinoline 1,5- benzoxazide substituted phenoxy piperazine derivatives
A series of 1,2,4-VA diazo 1,5-benzodiazo derivatives were synthesized by 1,3-dipolar cycloaddition of 1,5-benzothiazole derivatives with simple para-substituted chlorooximes.
2, synthesis and characterization of a new quinoline 1,2,4-VA two azoline derivative containing phenyl piperazine.
2-(4-phenylpiperazine-1-yl) -3-quinoline formaldehyde reacts with para-substituted aniline to obtain different imines. Then imines and simple para-substituted oximes react with 1,3-dipolar cycloaddition to obtain a series of quinoline-containing 1,2,4-VA diazoline derivatives.
3, synthesis and characterization of a new quinoline 1,3,4-VA two azoline derivative containing phenyl piperazine.
A series of new acylhydrazones were synthesized by the reaction of 2-(4-phenylpiperazine-1-yl) -3-quinoline formaldehyde with different substituted benzoylhydrazines. Then a series of new quinolino-containing 1,3,4-VA diazoline derivatives were obtained by oxidative ring-closure in acetic anhydride.
The structure of the product was confirmed by elemental analysis, MS, IR, 1H NMR and 13C NMR, and its spectral properties were analyzed and discussed.
【學位授予單位】:新疆大學
【學位級別】:碩士
【學位授予年份】:2014
【分類號】:O626
【參考文獻】
相關期刊論文 前10條
1 李小六;張宏波;朱振剛;陳華;段科芳;張平竹;;微波促進1,3-偶極環(huán)加成反應合成氮雜糖苷衍生物[J];高等學;瘜W學報;2010年09期
2 付曉鐘,袁牧,張玨,張振,劉香,張敏;1-(4-甲氧苯基)哌嗪鹽酸鹽的合成[J];貴陽醫(yī)學院學報;1999年04期
3 Divyesh C.Mungra;Harshad G.Kathrotiya;Niraj K.Ladani;Manish P.Patel;Ranjan G.Patel;;Molecular iodine catalyzed synthesis of tetrazolo[1,5-a]-quinoline based imidazoles as a new class of antimicrobial and antituberculosis agents[J];Chinese Chemical Letters;2012年12期
4 梁誠;;喹啉及其衍生物開發(fā)與應用[J];化工文摘;2004年02期
5 潘建林,陶蘭,幸勇,姚碧峰;N-苯基哌嗪的合成[J];中國現(xiàn)代應用藥學;2001年05期
6 陳慶華;;1,3-偶極環(huán)加成反應在有機合成方面的新進展[J];有機化學;1988年03期
7 張自義;陳立民;馮小明;曾福禮;;酰氨基硫脲及其相關雜環(huán)衍生物的研究——Ⅻ.1-(α-苯基氰乙酰胺基)-3-芳;螂寮3-(α-苯基氰甲基)-4-芳酰基-1,2,4-三唑-5-硫酚衍生物的合成[J];有機化學;1989年02期
8 陳慶華;謝孟\
本文編號:2233237
本文鏈接:http://sikaile.net/yixuelunwen/mazuiyixuelunwen/2233237.html